Deborah M. Autor's most recent trade in Hims & Hers Health Inc - Ordinary Shares - Class A was a trade of 32,919 Restricted Stock Unit done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 32,919 | 460,873 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 32,919 | 64,357 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.17 per share. | 15 Jun 2026 | 15,396 | 48,961 | - | 30.2 | 464,497 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 3,656 | 31,438 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 3,656 | 0 | - | - | Restricted Stock Unit | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 11 May 2026 | 34,819 | 93,660 (0%) | 0% | 12.9 | 450,558 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 34,819 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 34,819 | 128,479 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2026 | 19,824 | 19,824 | - | - | Restricted Stock Units | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 32,919 | 39,094 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2026 | 32,919 | 493,792 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.77 per share. | 13 Mar 2026 | 11,312 | 27,782 | - | 24.8 | 280,198 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 526,711 | 526,711 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Sale of securities on an exchange or to another person at price $ 36.71 per share. | 17 Dec 2025 | 7,054 | 6,175 | - | 36.7 | 258,952 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 7,054 | 13,229 | - | - | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 7,054 | 14,110 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 3,656 | 3,656 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,175 | 0 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,175 | 6,175 | - | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 93,660 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 34,819 | 34,819 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Sale of securities on an exchange or to another person at price $ 8.34 per share. | 21 Nov 2024 | 33,229 | 53,402 (0%) | 0% | 8.3 | 277,130 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Sale of securities on an exchange or to another person at price $ 8.41 per share. | 21 Nov 2024 | 6,771 | 86,631 (0%) | 0% | 8.4 | 56,944 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 21,164 | 21,164 | - | - | Restricted Stock Unit | |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 6,175 | 6,175 | - | - | Restricted Stock Unit | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Sale of securities on an exchange or to another person at price $ 6.73 per share. | 16 May 2024 | 23,447 | 93,402 (0%) | 0% | 6.7 | 157,728 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 16 May 2024 | 14,553 | 116,849 (0%) | 0% | 6.8 | 98,378 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 131,402 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 40,258 | 40,258 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2023 | 54,949 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2023 | 54,949 | 54,949 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 76,453 | 76,453 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Deborah M. Autor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 54,949 | 54,949 | - | - | Restricted Stock Units |